We collaborate with partners to design and build tailor-made 3D in vitro models that closely replicate human tissues and disease microenvioments.
These models are suitable for studying cancer biology, tissue regeneration, fibrosis, inflammation, and other disease mechanisms.
Gelomics offers end-to-end in vitro drug screening campaigns using our custom 3D models. Our in-house team designs and executes studies tailored to your drug pipeline, supporting early-stage candidate evaluation, lead optimization, and mechanism-of-action studies.
Capabilities include:
Whether you’re targeting oncology, inflammation, fibrosis, or tissue repair, our predictive models help derisk your preclinical decision-making.
Our team brings decades of expertise in 3D cell culture, developing advanced tissue models that closely mimic real biology for more accurate, predictive results.
We use the latest technologies and state-of-the-art facilities, including advanced imaging and analytics, to stay ahead of the curve.
Gelomics has a proven record of helping researchers overcome challenges, partnering with institutions and companies to deliver tailored, impactful solutions.
Advance tissue engineering projects with the LunaGel™ 3D tissue culture system.
Whether you’re looking to build a complex 3D disease model, run a preclinical drug screen, or tap into expert analytical services — Gelomics is here to help.
Contact us today to discuss your project and how we can collaborate
